TENX earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -10.49. Updated 2026-07-23.
Tenax Therapeutics (TENX) Research Hub
Tenax Therapeutics (TENX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.64 USD (-4.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.49, market cap 0.25B. This hub links to the full technical, earnings and options research available for TENX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.64 USD (-4.65%) |
| 52-week range | 1.36 USD – 19.4 USD |
| Trend regime | Range |
| 14-day RSI | 36.9 (Bearish) |
| Trailing P/E | -10.49 |
| Market cap | 0.25B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for TENX
Covered Call on TENX: how it works, illustrative setup around the real 1.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TENX: how it works, illustrative setup around the real 1.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TENX: how it works, illustrative setup around the real 1.64 USD price, max profit/loss, breakeven and when to use it. Educational.
TENX technical analysis: range, last 1.64 USD, RSI 36.9, 52w range 1.36 USD–19.4 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TENX in?
Tenax Therapeutics (TENX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TENX in an uptrend or downtrend?
As of 2026-10-26, TENX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TENX's trailing P/E ratio?
TENX's trailing P/E is -10.49, with a market cap of 0.25B. See the earnings research page for full valuation detail.
When does TENX next report earnings?
TENX is next scheduled to report earnings on 2026-08-12.